BlackRock’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.8M Buy
1,531,711
+1,186,351
+344% +$16.9M ﹤0.01% 2925
2025
Q1
$4.48M Buy
345,360
+27,735
+9% +$360K ﹤0.01% 3644
2024
Q4
$4.23M Buy
317,625
+32,770
+12% +$436K ﹤0.01% 3744
2024
Q3
$1.71M Buy
284,855
+2,466
+0.9% +$14.8K ﹤0.01% 3993
2024
Q2
$929K Sell
282,389
-563
-0.2% -$1.85K ﹤0.01% 4148
2024
Q1
$1.06M Sell
282,952
-1,289
-0.5% -$4.83K ﹤0.01% 4127
2023
Q4
$1.24M Sell
284,241
-935
-0.3% -$4.1K ﹤0.01% 4117
2023
Q3
$1.19M Sell
285,176
-13,049
-4% -$54.4K ﹤0.01% 4131
2023
Q2
$1.04M Buy
298,225
+5,560
+2% +$19.4K ﹤0.01% 4201
2023
Q1
$1.13M Buy
292,665
+1,914
+0.7% +$7.37K ﹤0.01% 4216
2022
Q4
$820K Buy
290,751
+590
+0.2% +$1.66K ﹤0.01% 4383
2022
Q3
$610K Sell
290,161
-1,552
-0.5% -$3.26K ﹤0.01% 4574
2022
Q2
$764K Sell
291,713
-4,826
-2% -$12.6K ﹤0.01% 4554
2022
Q1
$1.29M Sell
296,539
-2,403
-0.8% -$10.5K ﹤0.01% 4490
2021
Q4
$1.28M Sell
298,942
-1,955
-0.6% -$8.38K ﹤0.01% 4506
2021
Q3
$1.52M Sell
300,897
-161
-0.1% -$812 ﹤0.01% 4368
2021
Q2
$1.86M Sell
301,058
-785,208
-72% -$4.84M ﹤0.01% 4236
2021
Q1
$7.95M Buy
1,086,266
+33,321
+3% +$244K ﹤0.01% 3641
2020
Q4
$8.56M Buy
1,052,945
+59,350
+6% +$482K ﹤0.01% 3381
2020
Q3
$7.85M Buy
993,595
+292,175
+42% +$2.31M ﹤0.01% 3277
2020
Q2
$3.82M Buy
701,420
+628,047
+856% +$3.42M ﹤0.01% 3557
2020
Q1
$301K Sell
73,373
-437
-0.6% -$1.79K ﹤0.01% 4080
2019
Q4
$532K Buy
73,810
+36,874
+100% +$266K ﹤0.01% 4086
2019
Q3
$233K Buy
36,936
+10,844
+42% +$68.4K ﹤0.01% 4254
2019
Q2
$206K Buy
26,092
+16,813
+181% +$133K ﹤0.01% 4307
2019
Q1
$75K Sell
9,279
-630
-6% -$5.09K ﹤0.01% 4369
2018
Q4
$60K Buy
+9,909
New +$60K ﹤0.01% 4402